2016
DOI: 10.2337/dbi16-0055
|View full text |Cite
|
Sign up to set email alerts
|

Hyperpolarized 13C Magnetic Resonance Treatment Response Monitoring: A New Paradigm for Multiorgan Metabolic Assessment of Pharmacological Interventions?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 15 publications
(26 reference statements)
0
4
0
Order By: Relevance
“…Expression of the genes encoding regulatory enzymes PEPCK ( Pck1 ) and glucose-6-phosphatase ( G6pc) were both increased in kidney whereas only Pck1 expression was increased in heart, a non-gluconeogenic organ. Both of these sets of results suggested that hyperpolarized 13 C MR may be valuable in assessing systemic processes (exemplified by gluconeogenesis) in which various organs have distinct roles [ 117 ].…”
Section: Imaging Oxygen Consumption and Utilizationmentioning
confidence: 99%
See 1 more Smart Citation
“…Expression of the genes encoding regulatory enzymes PEPCK ( Pck1 ) and glucose-6-phosphatase ( G6pc) were both increased in kidney whereas only Pck1 expression was increased in heart, a non-gluconeogenic organ. Both of these sets of results suggested that hyperpolarized 13 C MR may be valuable in assessing systemic processes (exemplified by gluconeogenesis) in which various organs have distinct roles [ 117 ].…”
Section: Imaging Oxygen Consumption and Utilizationmentioning
confidence: 99%
“…The authors concluded that hyperpolarized 13 C-DHA enabled non-invasive assessment of redox capacity in diabetic renal injury and in response to treatment [ 78 ]. Oxidative stress is also the purported mechanism driving the CRS, and as such, progressive monitoring of the DHA/VitC ratio in models of primary and secondary CRS could provide important information regarding the interplay of the two organs [ 117 ].…”
Section: Imaging Oxygen Consumption and Utilizationmentioning
confidence: 99%
“…The ability to alter metabolic substrate selection and to monitor the metabolic consequence of treatment in real time is believed to be crucial in personalized medicine. This is particularly true in patients with abnormal metabolic patterns which could significantly alter the treatment response . In the normal heart, energy is primarily (>95%) produced via oxidative metabolism of free fatty acids (FFAs) and glucose, with each energy source contributing to ATP production at 60–90% and 10–40%, respectively .…”
Section: Introductionmentioning
confidence: 99%
“…This is particularly true in patients with abnormal metabolic patterns which could significantly alter the treatment response. 10,11 In the normal heart, energy is primarily (>95%) Abbreviations used: ANOVA, analysis of variance; AUC, area under the curve; CINE-LVF, CINE left ventricular function; CSI, chemical shift image; ECG, electrocardiogram; EF, ejection fraction; ELISA, enzyme-linked immunosorbent assay; FA, flip angle; FFA, free fatty acid; FOV, field of view; GIK, glucose-insulinpotassium; ICC, interclass correlation coefficient; MR, magnetic resonance; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; PET, positron emission tomography; RF, radiofrequency; ROI, region of interest produced via oxidative metabolism of free fatty acids (FFAs) and glucose, with each energy source contributing to ATP production at 60-90% and 10-40%, respectively. 12 These ratios vary widely under normal physiological conditions, e.g.…”
Section: Introductionmentioning
confidence: 99%